AQR Capital Management Portfolio holdings
AUM
$121B
1-Year Return
23.38%
This Quarter Return
+14.02%
1 Year Return
+23.38%
3 Year Return
+85.44%
5 Year Return
+156.19%
10 Year Return
+370.97%
AUM
$93.5B
AUM Growth
+$7.15B
(+8.3%)
Cap. Flow
-$3.38B
Cap. Flow
% of AUM
-3.61%
Top 10 Holdings %
Top 10 Hldgs %
12.67%
Holding
2,311
New
136
Increased
934
Reduced
1,002
Closed
155
Top Buys
| 1 |
Exelon
EXC
|
+$328M |
| 2 |
Procter & Gamble
PG
|
+$257M |
| 3 |
Biogen
BIIB
|
+$250M |
| 4 |
Starbucks
SBUX
|
+$197M |
| 5 |
TripAdvisor
TRIP
|
+$196M |
Top Sells
| 1 |
Target
TGT
|
+$565M |
| 2 |
Walmart
WMT
|
+$552M |
| 3 |
CELG
Celgene Corp
CELG
|
+$534M |
| 4 |
Costco
COST
|
+$342M |
| 5 |
Cigna
CI
|
+$321M |
Sector Composition
| 1 | Technology | 20.15% |
| 2 | Healthcare | 19.26% |
| 3 | Consumer Discretionary | 13.81% |
| 4 | Financials | 9.28% |
| 5 | Industrials | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Preferred Bank
PFBC
$1.17B
| $339K | ﹤0.01% |
7,541
-2,530
| -25% | -$114K |
|
1927
Western Union
WU
$2.73B
| $337K | ﹤0.01% |
18,264
-1,583
| -8% | -$29.2K |
|
1928
Avis
CAR
$5.48B
| $336K | ﹤0.01% |
9,645
+515
| +6% | +$17.9K |
|
1929
Kadant
KAI
$3.75B
| $336K | ﹤0.01% |
3,824
-13,361
| -78% | -$1.17M |
|
1930
Thor Industries
THO
$5.66B
| $335K | ﹤0.01% |
5,376
-202
| -4% | -$12.6K |
|
1931
Astronics
ATRO
$1.55B
| $333K | ﹤0.01% |
10,177
+1,674
| +20% | +$54.8K |
|
1932
Gibraltar Industries
ROCK
$1.79B
| $333K | ﹤0.01% |
8,205
+19
| +0.2% | +$771 |
|
1933
Smart Sand
SND
$75.1M
| $332K | ﹤0.01% |
74,530
-6,440
| -8% | -$28.7K |
|
1934
Vanda Pharmaceuticals
VNDA
$265M
| $330K | ﹤0.01% |
17,911
+3,916
| +28% | +$72.2K |
|
1935
BOK Financial
BOKF
$7.02B
| $329K | ﹤0.01% |
4,029
-19,196
| -83% | -$1.57M |
|
|
CPE
1936
DELISTED
Callon Petroleum Company
CPE
| $329K | ﹤0.01% |
4,352
-33,134
| -88% | -$2.5M |
|
1937
Marvell Technology
MRVL
$57.8B
| $328K | ﹤0.01% |
16,602
-60,215
| -78% | -$1.19M |
|
|
VIA
1938
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $328K | ﹤0.01% |
7,360
| – | – |
|
1939
Viking Therapeutics
VKTX
$2.91B
| $327K | ﹤0.01% |
32,900
-1,256
| -4% | -$12.5K |
|
|
VNTR
1940
DELISTED
Venator Materials PLC
VNTR
| $327K | ﹤0.01% |
58,195
+42,131
| +262% | +$237K |
|
1941
Harmonic Inc
HLIT
$1.12B
| $326K | ﹤0.01% |
60,063
+1,877
| +3% | +$10.2K |
|
1942
FibroGen
FGEN
$46.5M
| $325K | ﹤0.01% |
239
-80
| -25% | -$109K |
|
1943
Tucows
TCX
$194M
| $325K | ﹤0.01% |
3,998
-960
| -19% | -$78K |
|
1944
Heron Therapeutics
HRTX
$195M
| $323K | ﹤0.01% |
+13,202
| New | +$323K |
|
|
GTHX
1945
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $323K | ﹤0.01% |
19,447
-13,028
| -40% | -$216K |
|
|
CALA
1946
DELISTED
Calithera Biosciences, Inc
CALA
| $323K | ﹤0.01% |
2,396
-847
| -26% | -$114K |
|
|
DQ
1947
Daqo New Energy
DQ
$1.77B
| $320K | ﹤0.01% |
48,475
| – | – |
|
1948
Catalyst Pharmaceutical
CPRX
$2.42B
| $319K | ﹤0.01% |
62,597
-77,245
| -55% | -$394K |
|
1949
Coherus Oncology, Inc. Common Stock
CHRS
$152M
| $317K | ﹤0.01% |
23,267
-16,158
| -41% | -$220K |
|
1950
Old National Bancorp
ONB
$8.81B
| $317K | ﹤0.01% |
19,321
+3
| +0% | +$49 |
|